Enanta Pharma (ENTA) Announces Presentation of New Preclinical Data on EDP-305 in NASH at The Liver Meeting
Go back to Enanta Pharma (ENTA) Announces Presentation of New Preclinical Data on EDP-305 in NASH at The Liver MeetingENANTA PHARM (NASDAQ: ENTA) | Delayed: 13.32 +0.09 (0.68%) | |||||
---|---|---|---|---|---|---|
Previous Close | $13.23 | 52 Week High | $34.49 | |||
Open | $13.10 | 52 Week Low | $20.39 | |||
Day High | $13.44 | P/E | N/A | |||
Day Low | $12.77 | EPS | $-3.18 | |||
Volume | 139,429 |